Skip to main content

Olfactory dysfunction and quality of life in patients with transfusion-dependent thalassemia

Abstract

Transfusion-dependent thalassemia (TDT) is a group of thalassemia syndromes that require regular blood transfusions for survival. It is unknown whether the sense of smell of patients with TDT is affected, and if so, whether smell loss has an adverse effect on quality of life (QOL). Olfactory thresholds were measured using Snap & Sniff® wands. QOL was assessed via the Short Form-36 (SF-36) questionnaire. Forty-two TDT patients from the Thalassemia Center in Istanbul Medical Faculty were tested (mean age 26.6 years), along with 42 healthy controls (mean age 28.0 years). Mean olfactory sensitivity was lower in the TDT patients than the controls (p < 0.0001). TDT was associated with lower mean QOL scores on the domains of physical function (p < 0.0001), physical role limitation (p = 0.011), and general health (p < 0.0001). Within the TDT group, significant correlations were present between the threshold scores and physical function, physical role limitation, emotional role limitation, and general health. Patients with TDT are less sensitive to odors than healthy controls and the lower olfactory test scores are related to lower quality of life, suggesting that decreased smell function is an additional complication of this disease.

This is a preview of subscription content, access via your institution.

Abbreviations

TDT:

Transfusion dependent thalassemia

QOL:

Quality of life

OF:

Olfactory function

SF-36:

Short form-36

References

  1. Viprakasit V, Origa R (2014) Genetic basis, pathophysiology and diagnosis. In: Cappellini MD, Cohen A, Porter J, Taher A, Viprakasit V (eds) Guidelines for the management of transfusion dependent thalassaemia (TDT), 3rd edn. Thalassaemia International Federation (TIF) Publication, No. 20, Nicosia, pp 14–26

    Google Scholar 

  2. Nemtsas P, Arnaoutoglou M, Perifanis V, Koutsouraki E, Orologas A (2015) Neurological complications of beta-thalassemia. Ann Hematol 94(8):1261–1265

    CAS  Article  PubMed  Google Scholar 

  3. Borgna-Pignatti C (2010) The life of patients with thalassemia major. Haematologica 95(3):345–348

    Article  PubMed  PubMed Central  Google Scholar 

  4. Amid A, Saliba AN, Taher AT, Klaassen RJ (2015) Thalassaemia in children: from quality of care to quality of life. Arch Dis Child 100(11):1051–1057

    Article  PubMed  Google Scholar 

  5. World Health Organization (1995) The World Health Organization Quality of Life assessment (WHOQOL): position paper from the World Health Organization. Soc Sci Med 41:1403–1409

    Article  Google Scholar 

  6. Doty RL (2006) Olfactory dysfunction and its measurement in the clinic and workplace. Int Arch Occup Environ Health 79:268–282

    Article  PubMed  Google Scholar 

  7. Liu G, Zong G, Doty RL, Sun Q (2016) Prevalence and risk factors of taste and smell impairment in a nationwide representative sample of the US population: a cross-sectional study. BMJ Open 6(11):e013246

    Article  PubMed  PubMed Central  Google Scholar 

  8. Demiral Y, Ergor G, Unal B et al (2006) Normative data and discriminative properties of short form 36 (SF-36) in Turkish urban population. BMC Public Health 6:247

    Article  PubMed  PubMed Central  Google Scholar 

  9. Pinar R (2005) Reliability and construct validity of the SF-36 in Turkish cancer patients. Qual Life Res 14:259–264

    Article  PubMed  Google Scholar 

  10. Kocyigit H, Aydemir O, Fisek G, Olmez N, Memis A (1999) Validity and reliability of Turkish version of Short form 36: a study of a patients with romatoid disorder. J Drug Ther (in Turkish) 12:102–106

    Google Scholar 

  11. Ware JE, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30(6):473–483

    Article  PubMed  Google Scholar 

  12. Doty RL, Brugger WE, Jurs PC, Orndorff MA, Snyder PJ, Lowry LD (1978) Intranasal trigeminal stimulation from odorous volatiles: psychometric responses from anosmic and normal humans. Physiol Behav 20:175–185

    CAS  Article  PubMed  Google Scholar 

  13. Doty RL (2015) The Snap & Sniff® threshold test administration manual. Sensonics International, Haddon Hts

    Google Scholar 

  14. Doty RL (2015) Olfactory dysfunction and its measurement in the clinic. World J Otorhinolaryngol Head Neck Surg 1:28–33

    Article  Google Scholar 

  15. Santos DV, Reiter ER, DiNardo LJ, Costanzo RM (2004) Hazardous events associated with impaired olfactory function. Arch Otolaryngol Head Neck Surg 130(3):317–319

    Article  PubMed  Google Scholar 

  16. Devanand DP, Lee S, Manly J et al (2015) Olfactory identification deficits and increased mortality in the community. Ann Neurol 78(3):401–411

    Article  PubMed  PubMed Central  Google Scholar 

  17. Ginzburg Y, Rivella S (2011) Beta-thalassemia: a model for elucidating the dynamic regulation of ineffective erythropoiesis and iron metabolism. Blood 118(16):4321–4330

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  18. Rund D, Rachmilewitz E (2005) Beta-thalassemia. N Engl J Med 353:1135–1146

    CAS  Article  PubMed  Google Scholar 

  19. Shoham S, Youdim MB (2004) Nutritional iron deprivation attenuates kainate-induced neurotoxicity in rats: implications for involvement of iron in neurodegeneration. Ann NY Acad Sci 1012:94–114

    CAS  Article  PubMed  Google Scholar 

  20. Bulger M, van Doorninck JH, Saitoh N, Telling A, Farrell C, Bender MA et al (1999) Conservation of sequence and structure flanking the mouse and human beta-globin loci: the beta-globin genes are embedded within an array of odorant receptor genes. Proc Natl Acad Sci USA 96(9):5129–5134

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  21. Bulger M, Bender MA, van Doorninck JH et al (2000) Comparative structural and functional analysis of the olfactory receptor genes flanking the human and mouse beta-globin gene clusters. Proc Natl Acad Sci USA 97(26):14560–14565

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  22. Van Ziffle J, Yang W, Chehab FF (2011) Homozygous deletion of six olfactory receptor genes in a subset of individuals with beta-thalassemia. PLoS One 6(2):e17327

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We gratefully thank Mr. David Chapman for kindly providing language revision and Dilek Kaboglu and Sevda Gundag nurses for their great help during study.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Serap Karaman.

Ethics declarations

Ethical approval

Institutional Review Board (Istanbul University Istanbul Medical Faculty Clinical Research Ethic Committee) approval was obtained for this study (No. 2016/807).

Funding of study

This study received no extramural funding.

Conflict of interest

Yasin Yilmaz, Zeynep Karakas, Büsra Uzun, Cömert Sen, Senol Comoglu, Selime Aydogdu, Ayse Ozkan Karagenc, Deniz Tugcu, Serap Karaman, Kadir Serkan Orhan, and Crystal Wylie declare that they have no conflict of interest. Richard L. Doty is the President of Sensonics International, the manufacturer and distributor of the olfactory threshold test system employed in this study.

Informed consent

Informed consent was obtained from all patients for being included in the study.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Yilmaz, Y., Karakas, Z., Uzun, B. et al. Olfactory dysfunction and quality of life in patients with transfusion-dependent thalassemia. Eur Arch Otorhinolaryngol 274, 3417–3421 (2017). https://doi.org/10.1007/s00405-017-4668-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00405-017-4668-7

Keywords

  • Transfusion-dependent thalassemia
  • Olfactory dysfunction
  • Olfactory threshold
  • Psychophysics
  • SF-36
  • Quality of life